Insider Transactions in Q1 2023 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
David C Marek Principal Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
417,599
-61.46%
|
-
|
|
Mar 10
2023
|
Uneek Mehra Principal Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
202,696
-55.11%
|
-
|
|
Mar 10
2023
|
Lauren Merendino Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
169,538
-56.43%
|
-
|
|
Mar 10
2023
|
Myrtle S Potter Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,673
-100.0%
|
-
|
|
Mar 10
2023
|
Nancy Valente Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,673
-100.0%
|
-
|
|
Mar 10
2023
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
246,684
-67.55%
|
-
|
|
Mar 10
2023
|
Terrie Curran Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,673
-100.0%
|
-
|
|
Mar 10
2023
|
Mark Guinan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,673
-100.0%
|
-
|
|
Mar 10
2023
|
Adele M. Gulfo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,673
-100.0%
|
-
|
|
Mar 10
2023
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
354,303
-65.97%
|
-
|
|
Mar 10
2023
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
51,599,200
+52.98%
|
$1,393,178,400
$27.0 P/Share
|
|
Mar 03
2023
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,243,005
-8.48%
|
-
|
|
Jan 18
2023
|
Lauren Merendino Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,008
-1.17%
|
$52,208
$26.89 P/Share
|
|
Jan 18
2023
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,272
-0.36%
|
$33,072
$26.89 P/Share
|
|
Jan 18
2023
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,109
-0.45%
|
$28,834
$26.89 P/Share
|
|
Jan 18
2023
|
David C Marek Principal Executive Officer |
SELL
Open market or private sale
|
Direct |
8,037
-1.89%
|
$208,962
$26.89 P/Share
|
|
Jan 04
2023
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
2,779
-0.78%
|
$72,254
$26.9 P/Share
|
|
Jan 04
2023
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,251
-0.9%
|
$58,526
$26.9 P/Share
|